JP2023540733A5 - - Google Patents
Info
- Publication number
- JP2023540733A5 JP2023540733A5 JP2023514910A JP2023514910A JP2023540733A5 JP 2023540733 A5 JP2023540733 A5 JP 2023540733A5 JP 2023514910 A JP2023514910 A JP 2023514910A JP 2023514910 A JP2023514910 A JP 2023514910A JP 2023540733 A5 JP2023540733 A5 JP 2023540733A5
- Authority
- JP
- Japan
- Prior art keywords
- disease
- disorder
- compound according
- membered
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063074521P | 2020-09-04 | 2020-09-04 | |
| US63/074,521 | 2020-09-04 | ||
| PCT/US2021/049001 WO2022051582A1 (en) | 2020-09-04 | 2021-09-03 | Sulphamoyl urea derivatives containing alkyl-oxacycloalkyl moiety and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023540733A JP2023540733A (ja) | 2023-09-26 |
| JP2023540733A5 true JP2023540733A5 (enExample) | 2024-09-09 |
Family
ID=77951864
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023514910A Pending JP2023540733A (ja) | 2020-09-04 | 2021-09-03 | アルキルオキサシクロアルキル部分を含むスルファモイル尿素誘導体およびその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240043410A1 (enExample) |
| EP (1) | EP4208459A1 (enExample) |
| JP (1) | JP2023540733A (enExample) |
| KR (1) | KR20230061505A (enExample) |
| CN (1) | CN116783184A (enExample) |
| AR (1) | AR123435A1 (enExample) |
| BR (1) | BR112023003792A2 (enExample) |
| CA (1) | CA3191410A1 (enExample) |
| IL (1) | IL301055A (enExample) |
| MX (1) | MX2023002686A (enExample) |
| WO (1) | WO2022051582A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201721185D0 (en) | 2017-12-18 | 2018-01-31 | Nodthera Ltd | Sulphonyl urea derivatives |
| SI3983387T1 (sl) | 2019-06-12 | 2024-09-30 | NodThera Limited | Derivati sulfoniluree in njihove uporabe |
| ES3056339T3 (en) | 2019-06-12 | 2026-02-19 | Nodthera Ltd | Sulfonylurea derivatives and uses thereof |
| WO2025104244A1 (en) * | 2023-11-17 | 2025-05-22 | NodThera Limited | Methods of preparing urea derivatives |
| AU2024381716A1 (en) | 2023-11-17 | 2026-05-14 | NodThera Limited | Forms of urea derivatives and related uses |
| WO2025153532A1 (en) * | 2024-01-16 | 2025-07-24 | NodThera Limited | Nlrp3 inhibitors and glp-1 agonists combination therapies |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US5763263A (en) | 1995-11-27 | 1998-06-09 | Dehlinger; Peter J. | Method and apparatus for producing position addressable combinatorial libraries |
| JP3573757B2 (ja) | 1997-01-29 | 2004-10-06 | ファイザー・インク | スルホニルウレア誘導体、およびインターロイキン−１の活性を制御する上でのスルホニルウレア誘導体の使用 |
| HUE055755T2 (hu) * | 2015-02-16 | 2021-12-28 | Univ Queensland | Szulfonolkarmabidok és rokon vegyületeik valamint felhasználásuk |
| HUE066566T2 (hu) | 2017-07-24 | 2024-08-28 | Novartis Ag | Vegyületek és készítmények NLRP aktivitással összefüggõ állapotok kezelésére |
| GB201721185D0 (en) * | 2017-12-18 | 2018-01-31 | Nodthera Ltd | Sulphonyl urea derivatives |
| CN112672995A (zh) * | 2018-08-15 | 2021-04-16 | 英夫拉索姆有限公司 | 新型磺酰胺脲化合物 |
-
2021
- 2021-09-03 IL IL301055A patent/IL301055A/en unknown
- 2021-09-03 US US18/043,883 patent/US20240043410A1/en active Pending
- 2021-09-03 CN CN202180074301.7A patent/CN116783184A/zh active Pending
- 2021-09-03 WO PCT/US2021/049001 patent/WO2022051582A1/en not_active Ceased
- 2021-09-03 BR BR112023003792A patent/BR112023003792A2/pt unknown
- 2021-09-03 KR KR1020237011396A patent/KR20230061505A/ko active Pending
- 2021-09-03 CA CA3191410A patent/CA3191410A1/en active Pending
- 2021-09-03 MX MX2023002686A patent/MX2023002686A/es unknown
- 2021-09-03 JP JP2023514910A patent/JP2023540733A/ja active Pending
- 2021-09-03 AR ARP210102472A patent/AR123435A1/es unknown
- 2021-09-03 EP EP21778667.2A patent/EP4208459A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102833881B1 (ko) | 바이러스 감염 치료를 위한 화합물 및 방법 | |
| JP2022536160A5 (enExample) | ||
| JP2020528889A5 (enExample) | ||
| JP2019519598A5 (enExample) | ||
| JP6553551B2 (ja) | Ｂ型肝炎抗ウイルス剤 | |
| JP2022505525A5 (enExample) | ||
| JP2018531289A5 (enExample) | ||
| JP2022507506A5 (enExample) | ||
| EA020749B1 (ru) | Вич-ингибирующие 5,6-замещенные пиримидины | |
| HRP20250964T1 (hr) | Derivati sulfonil ureje kao modulatori nlrp3 inflamasoma | |
| JP2025524640A (ja) | Ｎｌｒｐ３インフラマソーム経路の調節剤としてのピロロトリアジン及びイミダゾトリアジン誘導体 | |
| JP2022535956A5 (enExample) | ||
| JP2022535955A5 (enExample) | ||
| JP2022506898A5 (enExample) | ||
| AU2022366992A1 (en) | Integrin inhibitors and uses thereof in combination with other agents | |
| HRP20240896T1 (hr) | Derivati sulfoniluree i njihova upotreba | |
| ES3028099T3 (en) | Polymorphic carbazole derivatives and uses thereof | |
| CN117940120A (zh) | 化合物、组合物和方法 | |
| JP2022522890A5 (enExample) | ||
| ES2895965T3 (es) | Moduladores del receptor de GABA(A) y métodos para controlar la hiperreactividad de las vías respiratorias y la inflamación en el asma | |
| ES2707675T3 (es) | Inhibidores de la replicación viral, su proceso de preparación y sus usos terapéuticos | |
| US20140342989A1 (en) | Novel N-Benzylamide Substituted Derivatives of 2-(Acylamido)acetic Acid and 2-(Acylamido)propionic Acids: Potent Neurological Agents | |
| JP2025504374A5 (enExample) | ||
| JP2022518526A5 (enExample) | ||
| JP2020518621A5 (enExample) |